This is a complete analysis of a real-world CRNA W-2 contract. Every section below — risk scores, red flags, negotiation language, plain-English translations — is exactly what you'd receive for your own contract.
Generated by ContractIQ's three-layer analysis engine: deterministic pre-scan → profession-calibrated AI → structured report.
12-category analysis · Deterministic pre-scan + calibrated AI · CRNA-specific severity thresholds
Average — Negotiable
Key findings from the three-layer analysis of this CRNA W-2 employment contract in Texas.
This W-2 employment agreement for a CRNA position contains several provisions that warrant careful attention before signing, particularly around the non-compete clause and tail coverage responsibility.
A 2-year, 35-mile non-compete with $150,000 in liquidated damages is above-average restrictiveness for the CRNA market. The median CRNA non-compete is 15–25 miles for 1–2 years.
Tail coverage is assigned entirely to the provider — this is a significant financial exposure that can cost $10,000–$40,000 for a CRNA depending on claims history.
Compensation of $210,000/year is at the 50th percentile for CRNAs nationally. No annual escalator clause means purchasing power declines with inflation.
The signing bonus of $25,000 has a full repayment clause with no proration — you would owe the entire amount back even if you leave one day before the 3-year term.
One-sided indemnification (provider indemnifies employer, but not vice versa) combined with a hold-harmless clause creates additional liability exposure.
35-mile radius with 2-year duration and $150K liquidated damages. Above 75th percentile in restrictiveness for CRNAs. Combined with non-solicitation, this significantly limits post-employment options.
90-day mutual notice is reasonable and standard. However, employer retains immediate for-cause termination without a cure period. No severance provision.
Claims-made policy provided by employer, which is standard. However, tail coverage cost is shifted entirely to provider — a significant gap.
$210K base is approximately the 50th percentile for CRNAs nationally ($185K–$240K typical range). No annual escalator or CPI adjustment clause identified.
1:4 call frequency is within standard range for CRNAs. $1,200/shift call pay is reasonable. No mandatory overtime clause.
Non-solicitation of patients and employees for 1 year post-termination. Combined with the 2-year non-compete, this creates a compounding restriction that significantly limits mobility.
Broad IP assignment clause covers all work product created during employment. Confidentiality obligation survives termination indefinitely with no sunset clause.
Standard compliance representation. No specific billing quota or productivity metric requirements identified.
No credentialing timeline or compensation during onboarding period specified. Standard for W-2 agreements.
Provider bears full cost of tail coverage upon separation. Extended reporting coverage for CRNAs typically costs $10,000–$40,000. This is the single largest financial risk in this contract. Most competitive CRNA offers include employer-paid tail.
Mandatory binding arbitration in Houston, TX. Waiver of jury trial. Arbitration is generally neutral but limits appeal options. Venue is reasonable if employment is in Houston metro.
One-sided indemnification — Provider indemnifies Employer but not vice versa. 'Hold harmless' language included. No carve-out for employer negligence.